TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12708207

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.1 microgram.Kg‐1.min.‐1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fentanyl (1 microgram.Kg‐1) and Midazolam (0.02 mg.Kg‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fentanyl and Midazolam
Number of subjects: 60
Study: 10532439

Group type: EXPERIMENTAL
Intervention: asp+IOL
Number of subjects: 74

Group type: COMPARATOR
Intervention: IOL-alone
Number of subjects: 74

Group type: COMPARATOR
Intervention: triple procedure
Number of subjects: 74
Study: 8696067

Group type: EXPERIMENTAL
Intervention: High blood pressure prevalence
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Non-insulin dependent diabetes mellitus prevalence
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Dyslipidemia prevalence
Number of subjects: 825
Study: 1997425

Group type: EXPERIMENTAL
Intervention: Oral immunization with Salmonella typhi Ty21a
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parenteral administration of heat‐killed typhoid vaccine
Number of subjects: 0
Study: 6340007

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 0
Study: 30787659

Group type: EXPERIMENTAL
Intervention: Beetroot juice with exercise (BJE, 200ml with ≈ 800mg nitrate and 40 minutes of moderate‐intensity aerobic exercise)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Beetroot juice with exercise (BJE)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fruit soda with exercise (FSE)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (CON, 200ml of water)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 14
Study: 29716912

Group type: EXPERIMENTAL
Intervention: High-intensity dynamic light (1700 lux)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control lighting (300 lux)
Number of subjects: 10
Study: 26825564

Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no abdominal massage)
Number of subjects: 60
Study: 25128877

Group type: EXPERIMENTAL
Intervention: Intense bout of cycling
Number of subjects: 32

Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 32
Study: 22072430

Group type: EXPERIMENTAL
Intervention: Ulimorelin 480 μg/kg
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 20658812

Group type: EXPERIMENTAL
Intervention: HOPES program (1 year of intensive skills training and health management, followed by a 1-year maintenance phase)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 183
Study: 18160764

Group type: EXPERIMENTAL
Intervention: Catechin (500 mg: equivalent to 6 or 7 cups of green tea)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 40
Study: 16968503

Group type: COMPARATOR
Intervention: Clarithromycin, amoxicillin, esomeprazole (Group A)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Clarithromycin, metronidazole, esomeprazole (Group B)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Clarithromycin, levofloxacin, esomeprazole (Group C)
Number of subjects: 300
Study: 15383130

Group type: EXPERIMENTAL
Intervention: Bipolar I depression patients
Number of subjects: 958
Study: 10908914

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CE)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Best medical care
Number of subjects: 90
Study: 8719715

Group type: EXPERIMENTAL
Intervention: Chorion Villus Sampling (CVS)
Number of subjects: 1492

Group type: COMPARATOR
Intervention: Early Amniocentesis (EA)
Number of subjects: 1492

Group type: EXPERIMENTAL
Intervention: Chorion Villus Sampling (CVS) and Early Amniocentesis (EA)
Number of subjects: 1492
Study: 1348405

Group type: EXPERIMENTAL
Intervention: 10 mg cetirizine
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 20 mg cetirizine
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 3906227

Group type: EXPERIMENTAL
Intervention: Bicarbonate dialysate
Number of subjects: 16

Group type: COMPARATOR
Intervention: Acetate dialysate
Number of subjects: 16
Study: 31690537

Group type: EXPERIMENTAL
Intervention: TN + Nutriluv (multimedia site in diabetes)
Number of subjects: 161

Group type: COMPARATOR
Intervention: TN (control group)
Number of subjects: 161
Study: 31229204

Group type: EXPERIMENTAL
Intervention: Lymphedema self-management program including training and a training booklet on exercise, massage, and prevention methods
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no self-management program)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Lymphedema self-management program
Number of subjects: 61
Study: 27890521

Group type: EXPERIMENTAL
Intervention: Financial incentives up to $520 for attending sessions and meeting weight loss goals
Number of subjects: 1154

Group type: COMPARATOR
Intervention: No financial incentives
Number of subjects: 1154
Study: 26452540

Group type: EXPERIMENTAL
Intervention: Xenon anesthesia
Number of subjects: 190

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 190
Study: 23390092

Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cell therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Peripheral blood progenitor cell therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 28
Study: 21393394

Group type: EXPERIMENTAL
Intervention: Heparin (unfractionated or low molecular weight [enoxaparin])
Number of subjects: 3994

Group type: COMPARATOR
Intervention: Fondaparinux
Number of subjects: 3994

Group type: COMPARATOR
Intervention: Heparin-treated patients (ELISA positive but platelet-activating antibody negative)
Number of subjects: 3994

Group type: COMPARATOR
Intervention: Heparin-treated antibody-negative control subjects
Number of subjects: 3994
Study: 19716489

Group type: EXPERIMENTAL
Intervention: Morphine-based postoperative PCA with preoperative anxiolytics prescribed
Number of subjects: 51

Group type: COMPARATOR
Intervention: Morphine-based postoperative PCA without preoperative anxiolytics prescribed
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Morphine-based postoperative PCA
Number of subjects: 51
Study: 17705990

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reperfusion
Number of subjects: 0
Study: 15281043

Group type: EXPERIMENTAL
Intervention: Yale Physical Activity Survey (YPAS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Derived EEPA
Number of subjects: 28
Study: 11478826

Group type: EXPERIMENTAL
Intervention: Enteral formula supplemented with 22 g/l partially hydrolyzed guar (soluble fiber)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous control feed without fiber
Number of subjects: 25
Study: 10453750

Group type: EXPERIMENTAL
Intervention: Pedalling rate of 40 rev.min(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pedalling rate of 60 rev.min(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pedalling rate of 80 rev.min(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pedalling rate of 100 rev.min(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pedalling rate of 120 rev.min(‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pedalling rate increase from 100 to 120 rev.min(‐1)
Number of subjects: 6
Study: 8555550

Group type: COMPARATOR
Intervention: Constant ultrafiltration with constant dialysate Na of 140 mEq/L (Group A)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sequentially decreasing ultrafiltration with constant dialysate Na (Group B)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sequentially decreasing ultrafiltration with sequentially decreasing dialysate Na from 150 to 140 mEq/L (Group C)
Number of subjects: 12
Study: 3310843

Group type: EXPERIMENTAL
Intervention: Baked rice (90 g, raw, cooked for 10 min at 160 degrees C after boiling)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Boiled rice (90 g, raw, boiled in salted water)
Number of subjects: 14
Study: 30817829

Group type: EXPERIMENTAL
Intervention: Optical interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized controlled trials
Number of subjects: 0
Study: 28428736

Group type: EXPERIMENTAL
Intervention: Fructose supplementation (4 g/kg BM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucose supplementation (4 g/kg BM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline (no sugar supplementation)
Number of subjects: 0
Study: 25913040

Group type: EXPERIMENTAL
Intervention: MMF + Pantoprazole (PAN) 40 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EC-MPS + Pantoprazole (PAN) 40 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EC-MPS + Pantoprazole (PAN)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MMF + Pantoprazole (PAN)
Number of subjects: 20

Group type: COMPARATOR
Intervention: MMF and EC-MPS
Number of subjects: 20
Study: 23473652

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) under dim light conditions (75 lx)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) under varying light conditions (585 lx and 1530 lx)
Number of subjects: 38
Study: 21763475

Group type: EXPERIMENTAL
Intervention: Surgical stabilization with plating
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 100
Study: 19492646

Group type: EXPERIMENTAL
Intervention: platform-enlarged implants
Number of subjects: 60

Group type: COMPARATOR
Intervention: control implants with an abutment as large as the implant platform
Number of subjects: 60

Group type: COMPARATOR
Intervention: control implants with a reduced abutment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: submerged implants with an enlarged platform
Number of subjects: 60
Study: 17108797

Group type: EXPERIMENTAL
Intervention: Therapeutic taping + physical therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Physical therapy only
Number of subjects: 18
Study: 15346082

Group type: EXPERIMENTAL
Intervention: Less Invasive Stabilization System (LISS)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Distal Femoral Nail
Number of subjects: 32

Group type: COMPARATOR
Intervention: Plate group (control)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Nail group (experimental)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both implants (LISS and distal femoral nail)
Number of subjects: 32
Study: 12661145

Group type: COMPARATOR
Intervention: Maternal ET‐1 levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fetal ET‐1 levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregnancy-induced hypertension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ET‐1 concentrations
Number of subjects: 0
Study: 10887713

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group intervention (6 weeks)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study: 8813864

Group type: EXPERIMENTAL
Intervention: Follow-on formula
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cows' milk
Number of subjects: 100
Study: 1480375

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (group B)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional tracheal tube (group A)
Number of subjects: 29
Study: 3902379

Group type: EXPERIMENTAL
Intervention: 600 mg bezafibrate per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: 300 mg fenofibrate per day
Number of subjects: 40
Study: 31415304

Group type: EXPERIMENTAL
Intervention: Cholecystectomy with cholangiogram within 24 hours of presentation (early group)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (cholecystectomy after clinical resolution)
Number of subjects: 97
Study: 30134187

Group type: EXPERIMENTAL
Intervention: MitraClip plus GDMT
Number of subjects: 614

Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 614
Study: 27123672

Group type: EXPERIMENTAL
Intervention: Parenting training (Triple P)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 100
Study: 24878112

Group type: EXPERIMENTAL
Intervention: HIV-exposed uninfected (HEU) children
Number of subjects: 327

Group type: COMPARATOR
Intervention: HIV-unexposed uninfected (HUU) children
Number of subjects: 327
Study: 22242678

Group type: COMPARATOR
Intervention: Desloratadine 5 mg daily for 6 weeks (Control)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Escalating doses of desloratadine: 5 mg daily for the first 2 weeks, 10 mg daily for the second 2 weeks, and 20 mg daily for the final 2 weeks (Intervention)
Number of subjects: 28
Study: 20489172

Group type: EXPERIMENTAL
Intervention: Lifetime risk for stroke at age 55 years
Number of subjects: 5498

Group type: EXPERIMENTAL
Intervention: Lifetime risk for cerebral infarction at age 55 years
Number of subjects: 5498

Group type: EXPERIMENTAL
Intervention: Lifetime risk for intracerebral hemorrhage at age 55 years
Number of subjects: 5498

Group type: EXPERIMENTAL
Intervention: Lifetime risk for stroke across index ages 45, 55, and 65 years
Number of subjects: 5498
Study: 18408525

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER 75 mg/day (up to 300 mg/day)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Citalopram 20 mg/day (up to 60 mg/day)
Number of subjects: 406
Study: 15741037

Group type: EXPERIMENTAL
Intervention: Tecnol bilateral facial ice packs
Number of subjects: 60

Group type: COMPARATOR
Intervention: No cold therapy (control)
Number of subjects: 60
Study: 12219851

Group type: EXPERIMENTAL
Intervention: Induction of positive mood in high caffeine consumers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Processing information about caffeine consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induction of positive mood
Number of subjects: 0
Study: 10420136

Group type: EXPERIMENTAL
Intervention: 0.16% RBG cream
Number of subjects: 66

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 66
Study: 7498396

Group type: EXPERIMENTAL
Intervention: Foot stimulation during walking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Foot stimulation just prior to footfall during walking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Foot stimulation immediately after footfall during walking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Somatosensory evoked potentials (P50-N80 complex) during gait
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Somatosensory evoked potentials (P50-N80 complex) just after footfall
Number of subjects: 0
Study: 2147235

Group type: EXPERIMENTAL
Intervention: Paroxetine 40 mg/day
Number of subjects: 19

Group type: COMPARATOR
Intervention: Imipramine (dose adjusted to optimal plasma levels of 400-600 nM)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 6988039

Group type: EXPERIMENTAL
Intervention: 100 micrograms inhaled salbutamol powder
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 micrograms inhaled salbutamol powder
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 800 micrograms inhaled salbutamol powder
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30334096

Group type: EXPERIMENTAL
Intervention: GLE/PIB treatment for 12 weeks
Number of subjects: 30
Study: 28350758

Group type: EXPERIMENTAL
Intervention: Vaginal gel containing 50μg estriol for 12 weeks (group A)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Estriol vaginal gel after surgery (group A1)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No estrogen treatment (group B)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Estriol treatment after surgery (group A1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: No estriol treatment after surgery (group A2)
Number of subjects: 75
Study: 25293727

Group type: EXPERIMENTAL
Intervention: Chemotherapy with external beam radiotherapy (EBRT) (45-50.4 Gy)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Chemotherapy without external beam radiotherapy (EBRT)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Chemotherapy with pre-anastomosis intraoperative electron radiation therapy (IOERT) boost (10-15 Gy)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Chemotherapy with external beam radiotherapy (EBRT)
Number of subjects: 95
Study: 23803042

Group type: EXPERIMENTAL
Intervention: Ginger supplement (750 mg per capsule, 4 capsules daily for 6 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Water-based exercise (4 times a week for 6 weeks, intensity ranging from 50% to 75% of heart rate reserve)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Water-based exercise + Ginger supplement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22292254

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO2), initiated within 1-3 days post-surgery, for at least 20 sessions (one session per day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO2)
Number of subjects: 120
Study: 19114904

Group type: EXPERIMENTAL
Intervention: Interactive voice and video demonstration and feedback (video group, n = 43)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Voice instruction alone (voice group, n = 53)
Number of subjects: 96
Study: 16725234

Group type: EXPERIMENTAL
Intervention: Combined hepatitis A/B vaccine Twinrix (GSK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Co-administered hepatitis A vaccine, Havrix (GSK) + hepatitis B vaccine Engerix-B (GSK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Co-administered hepatitis A vaccine, Vaqta (Sanofi-Pasteur MSD) + hepatitis B vaccine HB VAX PRO (Sanofi-Pasteur MSD)
Number of subjects: 0
Study: 15540757

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation (HoLEP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 100
Study: 11479155

Group type: EXPERIMENTAL
Intervention: Chronic renal failure patients (23 patients)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Patients with serum creatinine > 6 mg/dL (12 patients)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Maintenance hemodialysis (MHD) patients (26 patients)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: MHD patients with therapy longer than 10 years (8 patients)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Maintenance hemodiafiltration patients (15 patients)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (21 healthy subjects)
Number of subjects: 105
Study: 10096818

Group type: EXPERIMENTAL
Intervention: Active treatment (Gortex bags, high-powered vacuum cleaner, benzyl alcohol and tannic acid spray)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo treatment (light cotton bags, cheap vacuum cleaner, water spray)
Number of subjects: 48
Study: 7995325

Group type: EXPERIMENTAL
Intervention: 17 beta-oestradiol (9 mg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Progesterone (300 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 3281365

Group type: EXPERIMENTAL
Intervention: Emcyt
Number of subjects: 220

Group type: COMPARATOR
Intervention: flutamide
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Emcyt and flutamide
Number of subjects: 220
Study: 7646627

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 519960

Group type: EXPERIMENTAL
Intervention: Clonidine (300 micrograms orally)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31743071

Group type: EXPERIMENTAL
Intervention: Yoga-based lifestyle intervention (YBLI)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Dietary intervention (DI)
Number of subjects: 260
Study: 30712745

Group type: EXPERIMENTAL
Intervention: 2% lavender essential oil inhalation for 20 minutes every night for one month
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (distilled water) inhalation for 20 minutes every night for one month
Number of subjects: 62
Study: 28584187

Group type: EXPERIMENTAL
Intervention: ABP 501
Number of subjects: 526

Group type: COMPARATOR
Intervention: adalimumab (40 mg every 2 weeks)
Number of subjects: 526
Study: 28629293

Group type: EXPERIMENTAL
Intervention: Shugan Jieyu capsule
Number of subjects: 149

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 149
Study: 24934402

Group type: EXPERIMENTAL
Intervention: MAT-Fel d 1 vaccine
Number of subjects: 0
Study: 23115771

Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at a wavelength of 810 nm and an output power of 2 W for 5 × 5 seconds (Subgroup A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No irradiation (Subgroup B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BioPure MTAD
Number of subjects: 60
Study: 19923515

Group type: EXPERIMENTAL
Intervention: Flex-It stylet (FIS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Malleable stylet (control)
Number of subjects: 80
Study: 17868757

Group type: EXPERIMENTAL
Intervention: Measurement-based treatment protocols
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: STAR*D study
Number of subjects: 0
Study: 14551893

Group type: EXPERIMENTAL
Intervention: ChimeriVax-JE
Number of subjects: 99

Group type: COMPARATOR
Intervention: YF-VAX
Number of subjects: 99
Study: 11097537

Group type: EXPERIMENTAL
Intervention: Propofol (sufficient to eliminate brain electrical activity as measured on EEG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no propofol)
Number of subjects: 24
Study: 8899386

Group type: EXPERIMENTAL
Intervention: Projected length of the ROC curve (PLC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Area swept out by the ROC curve (ASC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Area under the curve (AUC)
Number of subjects: 0
Study: 1423468

Group type: EXPERIMENTAL
Intervention: 2000 m walking test
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 2000 m running time
Number of subjects: 38
Study: 2864530

Group type: EXPERIMENTAL
Intervention: Advice to rest in hospital from 32 weeks' gestation until delivery
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group offered selective hospital admission, on average, 5 weeks later
Number of subjects: 212